(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of -0.54% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Neogen's revenue in 2025 is $886,886,000.On average, 7 Wall Street analysts forecast NEOG's revenue for 2026 to be $182,152,746,231, with the lowest NEOG revenue forecast at $173,493,395,985, and the highest NEOG revenue forecast at $189,467,017,982. On average, 7 Wall Street analysts forecast NEOG's revenue for 2027 to be $185,568,680,631, with the lowest NEOG revenue forecast at $173,875,841,566, and the highest NEOG revenue forecast at $193,734,762,997.
In 2028, NEOG is forecast to generate $189,758,198,141 in revenue, with the lowest revenue forecast at $178,986,705,250 and the highest revenue forecast at $198,639,192,985.